Clinical Trials Browser

Phase 1/2 × Hydroxychloroquine × Tumor-Agnostic × Clear all

NCT01506973 2025-07-25

A Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane in Pancreatic Cancer

Phase 1/2 Completed

Adenocarcinoma